Clinical trials
Phase 3 Hypercholesterolemia trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Active, not recruiting | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 6 |
| Merck Sharp & Dohme LLC | 3 |
| Addpharma Inc. | 2 |
| Daewon Pharmaceutical Co., Ltd. | 2 |
| IlDong Pharmaceutical Co Ltd | 2 |
| Novartis Pharmaceuticals | 2 |
| Sanofi | 2 |
| Ahn-Gook Pharmaceuticals Co.,Ltd | 1 |
| AstraZeneca | 1 |
| Celltrion Pharm, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 25 |
| Dyslipidemias | 4 |
| Hyperlipidemias | 4 |
| Hypertension | 3 |
| Arteriosclerosis | 1 |
| Atherosclerosis | 1 |
| Essential Hypertension | 1 |
| Hyperlipoproteinemia Type II | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.